|
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimers Disease |
1F30AG077736-01 |
|
NIA |
2022 |
|
Quantitative Magnetization Transfer Imaging for Early Detection of Alzheimers Disease |
1F30AG077794-01 |
|
NIA |
2022 |
|
Treatment of Alzheimer’s Disease using Ultrasound-Targeted Microbubble Cavitation-Mediated Blood Brain Barrier Opening to Facilitate Drug Delivery to the Brain |
1F30AG077800-01 |
|
NIA |
2022 |
|
Leveraging Clinical Data for Phenotyping and Predictive Modelling of Alzheimer’s Disease |
1F30AG079504-01 |
|
NIA |
2022 |
|
Neurophysiological Basis for Functional Connectivity Changes in Early Alzheimer’s Disease |
1F30AG079507-01 |
|
NIA |
2022 |
|
The gut microbiome in Alzheimers disease: exploring the role of astrocytes |
1F30AG079577-01 |
|
NIA |
2022 |
|
Multimodal, multiclass prediction of disease status in Alzheimer’s |
1F30AG079610-01 |
|
NIA |
2022 |
|
AMPK localization, expression, and activity in Alzheimers Disease |
1F30AG079633-01 |
|
NIA |
2022 |
|
APOE4 Increases Astrocytic Tau Internalization to Promote Alzheimer’s-Related Neuronal Pathology |
1F31AG071131-01A1 |
|
NIA |
2022 |
|
Refining the Use of Polygenic Risk Scores for Alzheimers Disease in Diverse and Founder Populations |
1F31AG072715-01A1 |
|
NIA |
2022 |